site stats

Qlgn earnings

WebApr 6, 2024 · Qualigen Therapeutics (NASDAQ:QLGN) has a recorded annual revenue of $5.65 million. More Earnings Resources from MarketBeat Earnings Tools: Today's … Web18 hours ago · Compared to the aggregate P/E ratio of the 112.22 in the Health Care Equipment & Supplies industry, Align Tech Inc. has a lower P/E ratio of 74.05. …

Qualigen Therapeutics, Inc. (QLGN) Earnings EPS Surprise

WebQualigen Therapeutics, Inc. Common Stock (QLGN) Nasdaq Listed OUT OF COMPLIANCE Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Pre-Market … WebS100P Gene Expression May Be Marker of Anti-Tumor Activity in Pancreatic Cancer In Vivo Models CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential ... clear refrigerator https://benalt.net

Qualigen Therapeutics, Inc. (QLGN) - Yahoo Finance Canada

WebQualigen Therapeutics, Inc NASDAQQLGN 0.9300USD +0.0131 +1.43% At close as of Apr 4, 17:38 EDT No trades In Post-Market See on super-charts Overview News Ideas Financials … WebApr 5, 2024 · Qualigen Therapeutics - QLGN Price Target & Analyst Ratings $0.99 -0.06 (-5.72%) (As of 03/17/2024 12:00 AM ET) Compare Today's Range $0.99 $1.07 50-Day Range $0.99 $1.44 52-Week Range $0.99 $15.20 Volume 19,991 shs Average Volume 295,290 shs Market Capitalization $4.16 million P/E Ratio N/A Dividend Yield N/A Price Target $4.00 … WebApr 10, 2024 · In 2024, QLGN's revenue was $5.65 million, an increase of 1.72% compared to the previous year's $5.56 million. Losses were -$17.90 million, 901.2% more than in 2024. Financial Statements Analyst Forecast According to … clear refund covid

Qualigen Therapeutics, Inc. Common Stock (QLGN) - Nasdaq

Category:Erkenne unterbewertete Aktien mit einem Blick Eulerpool …

Tags:Qlgn earnings

Qlgn earnings

Erkenne unterbewertete Aktien mit einem Blick Eulerpool …

WebQualigen Therapeutics Price Targets What analysts think QLGN stock price will be. Current Price $1.14 Target Price $65 5,601.8% Upside $0 $69 Qualigen Therapeutics Stock Rating What analysts recommend for QLGN stock, on a scale from 1 (buy) to 5 (sell). Strong Buy Strong Buy 100% Buy 0% Hold 0% Sell 0% Strong Sell 0% WebGet the latest Qualigen Therapeutics Inc (QLGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

Qlgn earnings

Did you know?

WebP/E (TTM) -0.08 Fwd P/E (NTM) -0.63 EBITDA (TTM) -18.057M ROE (TTM) -145.43% Revenue (TTM) 5.075M Gross Margin (TTM) 12.77% Net Margin (TTM) -329.51% Debt To Equity … WebApr 15, 2024 · The company has a market cap of $26.27 billion, a price-to-earnings ratio of 74.25, a price-to-earnings-growth ratio of 3.30 and a beta of 1.60. Align Technology, Inc. …

WebMar 28, 2024 · QLGN Qualigen Therapeutics, Inc.Earnings Date & History. $0.89 -0.006 -0.67%) 3:56 PM 03/28/23. NASDAQ $USD Pre-Market: $0.99 +0.10 (+11.24%) 4:28 AM. … WebOverview Earnings & Estimates Qualigen Therapeutics Inc. Per Share Data Qualigen Therapeutics Inc. All values updated annually at fiscal year end Ratios & Margins Qualigen …

WebQualigen Therapeutics Inc (QLGN) Qualigen Therapeutics (QLGN) Earnings Date & Reports 532 Followers Portfolio Earnings Data Report Date May 11, 2024 Not Confirmed Period … WebNov 29, 2024 · CARLSBAD, Calif., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutic products for the treatment of...

WebApr 14, 2024 · NasdaqGS:ALGN Past Earnings Growth April 14th 2024. Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth …

WebApr 6, 2024 · Earnings are forecast to decline by an average of 11.6% per year for the next 3 years Does not have a meaningful market cap ($5M) Currently unprofitable and not forecast to become profitable over the next 3 years Shareholders have been diluted in the past year See all risk checks Snowflake Analysis My Notes blue shield customer serviceWebPer-Share Earnings, Actuals & Estimates Qualigen Therapeutics Inc. Quarterly Annual Actual Analyst Range Consensus 1.00 0.00 -1.00 -2.00 QLGN will report Q4 earnings on … clear refrigerator tubingWebErkenne unterbewertete Aktien mit einem Blick Eulerpool Research Systems ... English ... ... clearregionsWebApr 14, 2024 · The peg ratio is the share price relative to a company's earnings growth. A value between 0 and 1 is usually good and could indicate a company is undervalued (though much more research is needed as always). A value over 1.0 indcates a company may be overvalued given its shrinking earnings growth. A negative value means earnings have … blue shield customer service for providersWebQualigen Therapeutics (QLGN) reports earnings on 4/4/2024. Shares are up 418.2% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock … blue shield customer service phone numberWebApr 4, 2024 · Detailed statistics for Qualigen Therapeutics, Inc. (QLGN) stock, including valuation metrics, financial numbers, share information and more. ... Estimated Earnings Date May 12, 2024: Ex-Dividend Date n/a: Share Statistics. QLGN has 4.21 million shares outstanding. The number of shares has increased by 35.89% in one year. clear refrigerator containersWebNasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. blue shield customer service hours